The first 60 days: Clear cell ovarian cancer
Clear cell ovarian cancer grows out of endometriosis, is usually caught early and cured by surgery, but when advanced it resists platinum chemotherapy. Its distinct genetics, with ARID1A and PIK3CA mutations, are the focus of targeted and immune approaches. Below, week by week, is what OnCo's record of Clear cell ovarian cancer says about the first two months: the order is typical, the timing is yours to ask about. Sections appear only where the record has something to say. Orientation, not medical advice.
What happens now
Staging tests establish exactly what and where the cancer is. Everything else follows from the answers.
Ask which of these were tested and what the results were; see the report reader for what each value means.
These specialties appear in the standard of care for this cancer. In most centres they meet weekly as a tumour board to agree each plan; you can ask when yours was discussed and what was decided.
- SurgeonNamed in the standard of care for: Early stage.
- Medical oncologistNamed in the standard of care for: Early stage, Advanced or recurrent.
A second opinion from a centre that treats many similar cases is normal, not rude; the standard of care tells you what to compare it against.
Each row is a setting from the standard of care, in the order it usually arises. Not all will apply to you; your stage and biomarkers decide which do. The guideline grade, where recorded, says how strong the evidence is.
Complete staging surgery; adjuvant carboplatin-paclitaxel for stage IC and above; observation may be considered for stage IA.
Cytoreduction and platinum-based chemotherapy despite modest responses; clinical trials of immunotherapy and ARID1A-directed drugs are preferred where available.
Thromboprophylaxis awareness because of the high clot risk.
Generated from this cancer's standard of care, biomarkers and open problems. Take the group that matches where you are. To tick, add your own and print, open the one-page appointment sheet.
Newly diagnosed
- What is my exact diagnosis, stage, and grade, and which tests established them?Everything else follows from an accurate stage and subtype.
- Which biomarkers have been tested on my tumour (for example ARID1A mutation, PIK3CA mutation, HNF1B expression, Mismatch repair deficiency, Wild-type TP53), and what were the results?These results decide eligibility for targeted therapy, immunotherapy, and trials.
- Which subtype is my cancer, and does that change the recommended treatment?Recognised subtypes for this cancer include Clear cell carcinoma arising in endometriosis, Stage I clear cell carcinoma, Advanced and recurrent clear cell carcinoma.
- Is germline (inherited) genetic testing recommended for me or my family?Inherited variants can change treatment and matter for relatives.
Early stage
- For my situation (early stage), which of the standard options do you recommend and why?Guideline options include: Complete staging surgery; adjuvant carboplatin-paclitaxel for stage IC and above; observation may be considered for stage IA.
- Am I a candidate for Carboplatin, Paclitaxel / nab-paclitaxel, and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
Advanced or recurrent
- For my situation (advanced or recurrent), which of the standard options do you recommend and why?Guideline options include: Cytoreduction and platinum-based chemotherapy despite modest responses; clinical trials of immunotherapy and ARID1A-directed drugs are preferred where available.
- Am I a candidate for Pembrolizumab, and what side effects should I expect?Knowing the expected toxicities helps you plan work, family, and supportive care.
Supportive
- For my situation (supportive), which of the standard options do you recommend and why?Guideline options include: Thromboprophylaxis awareness because of the high clot risk.
Any stage
- Are there clinical trials I could join, for example of ATR and CHK1 inhibitors, Pembrolizumab?Trials are how the next standard of care is set; asking early keeps options open.
- Would a second opinion at a high-volume centre change anything, and can you help arrange it?Rare or high-stakes decisions benefit from a centre that treats many similar patients.
- What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?Supportive care improves quality of life and helps patients complete treatment.
- I read that “No effective treatment for platinum-resistant disease”. How does that affect my plan?Open problems are where trials and second opinions matter most.
- I read that “Which early-stage patients can skip chemotherapy”. How does that affect my plan?Open problems are where trials and second opinions matter most.
Much of what helps in the first weeks is free if you know to ask: testing, helplines, rides and lodging, second opinions, trial travel.
- Clear cell ovarian cancer: the full pageClear cell ovarian cancer grows out of endometriosis, is usually caught early and cured by surgery, but when advanced it resists platinum chemotherapy. Its distinct genetics, with ARID1A and PIK3CA mutations, are the focus of targeted and immune approaches.
- One-page appointment sheetYour questions, the words you may hear, what to bring, and space for the answers. Print it.
- Treatment sequencingWhich treatment tends to follow which, line by line.
- NavigatorStandard of care for your stage, what you have tried, and trials near you.